Human Gene CALR (ENST00000316448.10_6) from GENCODE V47lift37
Description: calreticulin (from RefSeq NM_004343.4)Gencode Transcript: ENST00000316448.10_6Gencode Gene: ENSG00000179218.15_8Transcript (Including UTRs) Position: hg19 chr19:13,049,423-13,055,303 Size: 5,881 Total Exon Count: 9 Strand: +Coding Region Position: hg19 chr19:13,049,494-13,054,727 Size: 5,234 Coding Exon Count: 9
Data last updated at UCSC: 2024-08-22 23:36:26
Sequence and Links to Tools and Databases
Primer design for this transcript
MalaCards Disease Associations
MalaCards Gene Search: CALR
Diseases sorted by gene-association score: myelofibrosis with myeloid metaplasia, somatic * (961), essential thrombocythemia * (550), thrombocythemia 1 * (520), calr-related essential thrombocythemia * (100), breast mucinous carcinoma (22), rubella (20), heart block, congenital (16), myeloperoxidase deficiency (13), myeloproliferative neoplasm (11), juvenile astrocytoma (10), maxillary sinus squamous cell carcinoma (10), budd-chiari syndrome (8), necatoriasis (7), chronic neutrophilic leukemia (7), onchocerciasis (7), chagas disease (7), polycythemia (6), catecholaminergic polymorphic ventricular tachycardia (6), trypanosomiasis (5), lupus erythematosus (5), intestinal volvulus (5), taeniasis (5), systemic lupus erythematosus (4), myopathy, tubular aggregate, 1 (3), thrombocytopenia-absent radius syndrome (3), celiac disease (3), dilated cardiomyopathy (1)* = Manually curated disease association
Comparative Toxicogenomics Database (CTD)
Common Gene Haplotype Alleles
Press "+" in the title bar above to open this section.
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
Microarray Expression Data
Press "+" in the title bar above to open this section.
mRNA Secondary Structure of 3' and 5' UTRs
Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Descriptions from all associated GenBank mRNAs
BC072002 - Homo sapiens calreticulin, mRNA (cDNA clone IMAGE:6262525), **** WARNING: chimeric clone ****.LF208184 - JP 2014500723-A/15687: Polycomb-Associated Non-Coding RNAs.LF373332 - JP 2014500723-A/180835: Polycomb-Associated Non-Coding RNAs.M84739 - Human autoantigen calreticulin mRNA, complete cds.AK295230 - Homo sapiens cDNA FLJ53009 complete cds, highly similar to Calreticulin precursor.AK304492 - Homo sapiens cDNA FLJ58668 complete cds, highly similar to Calreticulin precursor.FJ224311 - Homo sapiens epididymis secretory sperm binding protein Li 99n (HEL-S-99n) mRNA, complete cds.M32294 - Human Ro ribonucleoprotein autoantigen (Ro/SS-A), complete cds.BC007911 - Homo sapiens calreticulin, mRNA (cDNA clone MGC:14363 IMAGE:4299303), complete cds.BC020493 - Homo sapiens calreticulin, mRNA (cDNA clone MGC:10100 IMAGE:3898550), complete cds.GQ900919 - Homo sapiens clone HEL-T-31 epididymis secretory sperm binding protein mRNA, complete cds.BC052621 - Homo sapiens cDNA clone IMAGE:6578175, **** WARNING: chimeric clone ****.AY047586 - Homo sapiens calreticulin (CALR) mRNA, complete cds.BC002500 - Homo sapiens calreticulin, mRNA (cDNA clone MGC:2227 IMAGE:3050717), complete cds.AB385014 - Synthetic construct DNA, clone: pF1KB5014, Homo sapiens CALR gene for calreticulin precursor, complete cds, without stop codon, in Flexi system.KJ890816 - Synthetic construct Homo sapiens clone ccsbBroadEn_00210 CALR gene, encodes complete protein.CR457070 - Homo sapiens full open reading frame cDNA clone RZPDo834G0511D for gene CALR, calreticulin; complete cds, incl. stopcodon.AB451408 - Homo sapiens CALR mRNA for calreticulin precursor, partial cds, clone: FLJ08113AAAF.BT007448 - Homo sapiens calreticulin mRNA, complete cds.LP633929 - Sequence 147 from Patent WO2015036599.LP633933 - Sequence 151 from Patent WO2015036599.LP633937 - Sequence 155 from Patent WO2015036599.LP633941 - Sequence 159 from Patent WO2015036599.LP633945 - Sequence 163 from Patent WO2015036599.LP633949 - Sequence 167 from Patent WO2015036599.LP633953 - Sequence 171 from Patent WO2015036599.LP633957 - Sequence 175 from Patent WO2015036599.LP633961 - Sequence 179 from Patent WO2015036599.LP633965 - Sequence 183 from Patent WO2015036599.LP633969 - Sequence 187 from Patent WO2015036599.LP633973 - Sequence 191 from Patent WO2015036599.LP633977 - Sequence 195 from Patent WO2015036599.LP633981 - Sequence 199 from Patent WO2015036599.LP633985 - Sequence 203 from Patent WO2015036599.LP633989 - Sequence 207 from Patent WO2015036599.LP633993 - Sequence 211 from Patent WO2015036599.LP633997 - Sequence 215 from Patent WO2015036599.LP634001 - Sequence 219 from Patent WO2015036599.LP634005 - Sequence 223 from Patent WO2015036599.LP634009 - Sequence 227 from Patent WO2015036599.LP634013 - Sequence 231 from Patent WO2015036599.LP634017 - Sequence 235 from Patent WO2015036599.LP634021 - Sequence 239 from Patent WO2015036599.LP634025 - Sequence 243 from Patent WO2015036599.LP634029 - Sequence 247 from Patent WO2015036599.LP634033 - Sequence 251 from Patent WO2015036599.LP634037 - Sequence 255 from Patent WO2015036599.LP634041 - Sequence 259 from Patent WO2015036599.LP634045 - Sequence 263 from Patent WO2015036599.LP634049 - Sequence 267 from Patent WO2015036599.LP634053 - Sequence 271 from Patent WO2015036599.LP634057 - Sequence 275 from Patent WO2015036599.LP634061 - Sequence 279 from Patent WO2015036599.LP634065 - Sequence 283 from Patent WO2015036599.LP634069 - Sequence 287 from Patent WO2015036599.LQ447312 - Sequence 147 from Patent EP3020727.LQ447316 - Sequence 151 from Patent EP3020727.LQ447320 - Sequence 155 from Patent EP3020727.LQ447324 - Sequence 159 from Patent EP3020727.LQ447328 - Sequence 163 from Patent EP3020727.LQ447332 - Sequence 167 from Patent EP3020727.LQ447336 - Sequence 171 from Patent EP3020727.LQ447340 - Sequence 175 from Patent EP3020727.LQ447344 - Sequence 179 from Patent EP3020727.LQ447348 - Sequence 183 from Patent EP3020727.LQ447352 - Sequence 187 from Patent EP3020727.LQ447356 - Sequence 191 from Patent EP3020727.LQ447360 - Sequence 195 from Patent EP3020727.LQ447364 - Sequence 199 from Patent EP3020727.LQ447368 - Sequence 203 from Patent EP3020727.LQ447372 - Sequence 207 from Patent EP3020727.LQ447376 - Sequence 211 from Patent EP3020727.LQ447380 - Sequence 215 from Patent EP3020727.LQ447384 - Sequence 219 from Patent EP3020727.LQ447388 - Sequence 223 from Patent EP3020727.LQ447392 - Sequence 227 from Patent EP3020727.LQ447396 - Sequence 231 from Patent EP3020727.LQ447400 - Sequence 235 from Patent EP3020727.LQ447404 - Sequence 239 from Patent EP3020727.LQ447408 - Sequence 243 from Patent EP3020727.LQ447412 - Sequence 247 from Patent EP3020727.LQ447416 - Sequence 251 from Patent EP3020727.LQ447420 - Sequence 255 from Patent EP3020727.LQ447424 - Sequence 259 from Patent EP3020727.LQ447428 - Sequence 263 from Patent EP3020727.LQ447432 - Sequence 267 from Patent EP3020727.LQ447436 - Sequence 271 from Patent EP3020727.LQ447440 - Sequence 275 from Patent EP3020727.LQ447444 - Sequence 279 from Patent EP3020727.LQ447448 - Sequence 283 from Patent EP3020727.LQ447452 - Sequence 287 from Patent EP3020727.LQ789314 - Sequence 147 from Patent EP3339318.LQ789318 - Sequence 151 from Patent EP3339318.LQ789322 - Sequence 155 from Patent EP3339318.LQ789326 - Sequence 159 from Patent EP3339318.LQ789330 - Sequence 163 from Patent EP3339318.LQ789334 - Sequence 167 from Patent EP3339318.LQ789338 - Sequence 171 from Patent EP3339318.LQ789342 - Sequence 175 from Patent EP3339318.LQ789346 - Sequence 179 from Patent EP3339318.LQ789350 - Sequence 183 from Patent EP3339318.LQ789354 - Sequence 187 from Patent EP3339318.LQ789358 - Sequence 191 from Patent EP3339318.LQ789362 - Sequence 195 from Patent EP3339318.LQ789366 - Sequence 199 from Patent EP3339318.LQ789370 - Sequence 203 from Patent EP3339318.LQ789374 - Sequence 207 from Patent EP3339318.LQ789378 - Sequence 211 from Patent EP3339318.LQ789382 - Sequence 215 from Patent EP3339318.LQ789386 - Sequence 219 from Patent EP3339318.LQ789390 - Sequence 223 from Patent EP3339318.LQ789394 - Sequence 227 from Patent EP3339318.LQ789398 - Sequence 231 from Patent EP3339318.LQ789402 - Sequence 235 from Patent EP3339318.LQ789406 - Sequence 239 from Patent EP3339318.LQ789410 - Sequence 243 from Patent EP3339318.LQ789414 - Sequence 247 from Patent EP3339318.LQ789418 - Sequence 251 from Patent EP3339318.LQ789422 - Sequence 255 from Patent EP3339318.LQ789426 - Sequence 259 from Patent EP3339318.LQ789430 - Sequence 263 from Patent EP3339318.LQ789434 - Sequence 267 from Patent EP3339318.LQ789438 - Sequence 271 from Patent EP3339318.LQ789442 - Sequence 275 from Patent EP3339318.LQ789446 - Sequence 279 from Patent EP3339318.LQ789450 - Sequence 283 from Patent EP3339318.LQ789454 - Sequence 287 from Patent EP3339318.LV525549 - JP 2016537012-A/111: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525552 - JP 2016537012-A/114: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525555 - JP 2016537012-A/117: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525558 - JP 2016537012-A/120: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525561 - JP 2016537012-A/123: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525564 - JP 2016537012-A/126: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525567 - JP 2016537012-A/129: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525570 - JP 2016537012-A/132: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525573 - JP 2016537012-A/135: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525576 - JP 2016537012-A/138: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525579 - JP 2016537012-A/141: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525582 - JP 2016537012-A/144: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525585 - JP 2016537012-A/147: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525588 - JP 2016537012-A/150: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525591 - JP 2016537012-A/153: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525594 - JP 2016537012-A/156: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525597 - JP 2016537012-A/159: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525600 - JP 2016537012-A/162: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525603 - JP 2016537012-A/165: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525606 - JP 2016537012-A/168: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525609 - JP 2016537012-A/171: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525612 - JP 2016537012-A/174: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525615 - JP 2016537012-A/177: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525618 - JP 2016537012-A/180: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525621 - JP 2016537012-A/183: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525624 - JP 2016537012-A/186: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525627 - JP 2016537012-A/189: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525630 - JP 2016537012-A/192: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525633 - JP 2016537012-A/195: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525636 - JP 2016537012-A/198: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525639 - JP 2016537012-A/201: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525642 - JP 2016537012-A/204: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525645 - JP 2016537012-A/207: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525648 - JP 2016537012-A/210: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525651 - JP 2016537012-A/213: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525654 - JP 2016537012-A/216: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289264 - KR 1020160068754-A/147: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289267 - KR 1020160068754-A/151: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289270 - KR 1020160068754-A/155: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289273 - KR 1020160068754-A/159: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289276 - KR 1020160068754-A/163: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289279 - KR 1020160068754-A/167: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289282 - KR 1020160068754-A/171: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289285 - KR 1020160068754-A/175: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289288 - KR 1020160068754-A/179: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289291 - KR 1020160068754-A/183: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289294 - KR 1020160068754-A/187: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289297 - KR 1020160068754-A/191: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289300 - KR 1020160068754-A/195: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289303 - KR 1020160068754-A/199: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289306 - KR 1020160068754-A/203: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289309 - KR 1020160068754-A/207: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289312 - KR 1020160068754-A/211: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289315 - KR 1020160068754-A/215: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289318 - KR 1020160068754-A/219: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289321 - KR 1020160068754-A/223: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289324 - KR 1020160068754-A/227: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289327 - KR 1020160068754-A/231: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289330 - KR 1020160068754-A/235: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289333 - KR 1020160068754-A/239: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289336 - KR 1020160068754-A/243: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289339 - KR 1020160068754-A/247: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289342 - KR 1020160068754-A/251: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289345 - KR 1020160068754-A/255: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289348 - KR 1020160068754-A/259: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289351 - KR 1020160068754-A/263: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289354 - KR 1020160068754-A/267: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289357 - KR 1020160068754-A/271: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289360 - KR 1020160068754-A/275: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289363 - KR 1020160068754-A/279: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289366 - KR 1020160068754-A/283: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289369 - KR 1020160068754-A/287: Mutant calreticulin for the diagnosis of myeloid malignancies.AK223060 - Homo sapiens mRNA for calreticulin precursor variant, clone: JTH13773.LF373331 - JP 2014500723-A/180834: Polycomb-Associated Non-Coding RNAs.AF087986 - Homo sapiens full length insert cDNA clone YX19H04.LF373329 - JP 2014500723-A/180832: Polycomb-Associated Non-Coding RNAs.LF373328 - JP 2014500723-A/180831: Polycomb-Associated Non-Coding RNAs.LF373327 - JP 2014500723-A/180830: Polycomb-Associated Non-Coding RNAs.LF373326 - JP 2014500723-A/180829: Polycomb-Associated Non-Coding RNAs.LF373325 - JP 2014500723-A/180828: Polycomb-Associated Non-Coding RNAs.AK130190 - Homo sapiens cDNA FLJ26680 fis, clone MPG04548, highly similar to Calreticulin precursor.DL492170 - Novel nucleic acids.LF373324 - JP 2014500723-A/180827: Polycomb-Associated Non-Coding RNAs.LF373323 - JP 2014500723-A/180826: Polycomb-Associated Non-Coding RNAs.LF373322 - JP 2014500723-A/180825: Polycomb-Associated Non-Coding RNAs.LP634075 - Sequence 293 from Patent WO2015036599.LP634079 - Sequence 297 from Patent WO2015036599.LP634083 - Sequence 301 from Patent WO2015036599.LP634087 - Sequence 305 from Patent WO2015036599.LP634091 - Sequence 309 from Patent WO2015036599.LP634095 - Sequence 313 from Patent WO2015036599.LP634099 - Sequence 317 from Patent WO2015036599.LP634103 - Sequence 321 from Patent WO2015036599.LP634107 - Sequence 325 from Patent WO2015036599.LP634111 - Sequence 329 from Patent WO2015036599.LP634115 - Sequence 333 from Patent WO2015036599.LP634119 - Sequence 337 from Patent WO2015036599.LP634123 - Sequence 341 from Patent WO2015036599.LP634127 - Sequence 345 from Patent WO2015036599.LP634131 - Sequence 349 from Patent WO2015036599.LP634135 - Sequence 353 from Patent WO2015036599.LP634139 - Sequence 357 from Patent WO2015036599.LP634143 - Sequence 361 from Patent WO2015036599.LP634147 - Sequence 365 from Patent WO2015036599.LP634151 - Sequence 369 from Patent WO2015036599.LP634155 - Sequence 373 from Patent WO2015036599.LP634159 - Sequence 377 from Patent WO2015036599.LP634163 - Sequence 381 from Patent WO2015036599.LP634167 - Sequence 385 from Patent WO2015036599.LP634171 - Sequence 389 from Patent WO2015036599.LP634175 - Sequence 393 from Patent WO2015036599.LP634179 - Sequence 397 from Patent WO2015036599.LP634183 - Sequence 401 from Patent WO2015036599.LP634187 - Sequence 405 from Patent WO2015036599.LP634191 - Sequence 409 from Patent WO2015036599.LP634195 - Sequence 413 from Patent WO2015036599.LP634199 - Sequence 417 from Patent WO2015036599.LP634203 - Sequence 421 from Patent WO2015036599.LP634207 - Sequence 425 from Patent WO2015036599.LP634211 - Sequence 429 from Patent WO2015036599.LP634215 - Sequence 433 from Patent WO2015036599.LQ447458 - Sequence 293 from Patent EP3020727.LQ447462 - Sequence 297 from Patent EP3020727.LQ447466 - Sequence 301 from Patent EP3020727.LQ447470 - Sequence 305 from Patent EP3020727.LQ447474 - Sequence 309 from Patent EP3020727.LQ447478 - Sequence 313 from Patent EP3020727.LQ447482 - Sequence 317 from Patent EP3020727.LQ447486 - Sequence 321 from Patent EP3020727.LQ447490 - Sequence 325 from Patent EP3020727.LQ447494 - Sequence 329 from Patent EP3020727.LQ447498 - Sequence 333 from Patent EP3020727.LQ447502 - Sequence 337 from Patent EP3020727.LQ447506 - Sequence 341 from Patent EP3020727.LQ447510 - Sequence 345 from Patent EP3020727.LQ447514 - Sequence 349 from Patent EP3020727.LQ447518 - Sequence 353 from Patent EP3020727.LQ447522 - Sequence 357 from Patent EP3020727.LQ447526 - Sequence 361 from Patent EP3020727.LQ447530 - Sequence 365 from Patent EP3020727.LQ447534 - Sequence 369 from Patent EP3020727.LQ447538 - Sequence 373 from Patent EP3020727.LQ447542 - Sequence 377 from Patent EP3020727.LQ447546 - Sequence 381 from Patent EP3020727.LQ447550 - Sequence 385 from Patent EP3020727.LQ447554 - Sequence 389 from Patent EP3020727.LQ447558 - Sequence 393 from Patent EP3020727.LQ447562 - Sequence 397 from Patent EP3020727.LQ447566 - Sequence 401 from Patent EP3020727.LQ447570 - Sequence 405 from Patent EP3020727.LQ447574 - Sequence 409 from Patent EP3020727.LQ447578 - Sequence 413 from Patent EP3020727.LQ447582 - Sequence 417 from Patent EP3020727.LQ447586 - Sequence 421 from Patent EP3020727.LQ447590 - Sequence 425 from Patent EP3020727.LQ447594 - Sequence 429 from Patent EP3020727.LQ447598 - Sequence 433 from Patent EP3020727.LQ789460 - Sequence 293 from Patent EP3339318.LQ789464 - Sequence 297 from Patent EP3339318.LQ789468 - Sequence 301 from Patent EP3339318.LQ789472 - Sequence 305 from Patent EP3339318.LQ789476 - Sequence 309 from Patent EP3339318.LQ789480 - Sequence 313 from Patent EP3339318.LQ789484 - Sequence 317 from Patent EP3339318.LQ789488 - Sequence 321 from Patent EP3339318.LQ789492 - Sequence 325 from Patent EP3339318.LQ789496 - Sequence 329 from Patent EP3339318.LQ789500 - Sequence 333 from Patent EP3339318.LQ789504 - Sequence 337 from Patent EP3339318.LQ789508 - Sequence 341 from Patent EP3339318.LQ789512 - Sequence 345 from Patent EP3339318.LQ789516 - Sequence 349 from Patent EP3339318.LQ789520 - Sequence 353 from Patent EP3339318.LQ789524 - Sequence 357 from Patent EP3339318.LQ789528 - Sequence 361 from Patent EP3339318.LQ789532 - Sequence 365 from Patent EP3339318.LQ789536 - Sequence 369 from Patent EP3339318.LQ789540 - Sequence 373 from Patent EP3339318.LQ789544 - Sequence 377 from Patent EP3339318.LQ789548 - Sequence 381 from Patent EP3339318.LQ789552 - Sequence 385 from Patent EP3339318.LQ789556 - Sequence 389 from Patent EP3339318.LQ789560 - Sequence 393 from Patent EP3339318.LQ789564 - Sequence 397 from Patent EP3339318.LQ789568 - Sequence 401 from Patent EP3339318.LQ789572 - Sequence 405 from Patent EP3339318.LQ789576 - Sequence 409 from Patent EP3339318.LQ789580 - Sequence 413 from Patent EP3339318.LQ789584 - Sequence 417 from Patent EP3339318.LQ789588 - Sequence 421 from Patent EP3339318.LQ789592 - Sequence 425 from Patent EP3339318.LQ789596 - Sequence 429 from Patent EP3339318.LQ789600 - Sequence 433 from Patent EP3339318.LV525658 - JP 2016537012-A/220: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525661 - JP 2016537012-A/223: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525664 - JP 2016537012-A/226: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525667 - JP 2016537012-A/229: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525670 - JP 2016537012-A/232: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525673 - JP 2016537012-A/235: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525676 - JP 2016537012-A/238: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525679 - JP 2016537012-A/241: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525682 - JP 2016537012-A/244: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525685 - JP 2016537012-A/247: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525688 - JP 2016537012-A/250: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525691 - JP 2016537012-A/253: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525694 - JP 2016537012-A/256: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525697 - JP 2016537012-A/259: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525700 - JP 2016537012-A/262: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525703 - JP 2016537012-A/265: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525706 - JP 2016537012-A/268: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525709 - JP 2016537012-A/271: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525712 - JP 2016537012-A/274: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525715 - JP 2016537012-A/277: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525718 - JP 2016537012-A/280: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525721 - JP 2016537012-A/283: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525724 - JP 2016537012-A/286: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525727 - JP 2016537012-A/289: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525730 - JP 2016537012-A/292: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525733 - JP 2016537012-A/295: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525736 - JP 2016537012-A/298: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525739 - JP 2016537012-A/301: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525742 - JP 2016537012-A/304: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525745 - JP 2016537012-A/307: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525748 - JP 2016537012-A/310: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525751 - JP 2016537012-A/313: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525754 - JP 2016537012-A/316: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525757 - JP 2016537012-A/319: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525760 - JP 2016537012-A/322: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525763 - JP 2016537012-A/325: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289373 - KR 1020160068754-A/293: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289376 - KR 1020160068754-A/297: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289379 - KR 1020160068754-A/301: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289382 - KR 1020160068754-A/305: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289385 - KR 1020160068754-A/309: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289388 - KR 1020160068754-A/313: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289391 - KR 1020160068754-A/317: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289394 - KR 1020160068754-A/321: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289397 - KR 1020160068754-A/325: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289400 - KR 1020160068754-A/329: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289403 - KR 1020160068754-A/333: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289406 - KR 1020160068754-A/337: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289409 - KR 1020160068754-A/341: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289412 - KR 1020160068754-A/345: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289415 - KR 1020160068754-A/349: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289418 - KR 1020160068754-A/353: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289421 - KR 1020160068754-A/357: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289424 - KR 1020160068754-A/361: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289427 - KR 1020160068754-A/365: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289430 - KR 1020160068754-A/369: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289433 - KR 1020160068754-A/373: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289436 - KR 1020160068754-A/377: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289439 - KR 1020160068754-A/381: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289442 - KR 1020160068754-A/385: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289445 - KR 1020160068754-A/389: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289448 - KR 1020160068754-A/393: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289451 - KR 1020160068754-A/397: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289454 - KR 1020160068754-A/401: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289457 - KR 1020160068754-A/405: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289460 - KR 1020160068754-A/409: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289463 - KR 1020160068754-A/413: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289466 - KR 1020160068754-A/417: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289469 - KR 1020160068754-A/421: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289472 - KR 1020160068754-A/425: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289475 - KR 1020160068754-A/429: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289478 - KR 1020160068754-A/433: Mutant calreticulin for the diagnosis of myeloid malignancies.LF373321 - JP 2014500723-A/180824: Polycomb-Associated Non-Coding RNAs.LP633869 - Sequence 87 from Patent WO2015036599.LP633885 - Sequence 103 from Patent WO2015036599.LQ447252 - Sequence 87 from Patent EP3020727.LQ447268 - Sequence 103 from Patent EP3020727.LQ789254 - Sequence 87 from Patent EP3339318.LQ789270 - Sequence 103 from Patent EP3339318.LV525504 - JP 2016537012-A/66: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525516 - JP 2016537012-A/78: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289219 - KR 1020160068754-A/87: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289231 - KR 1020160068754-A/103: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633889 - Sequence 107 from Patent WO2015036599.LQ447272 - Sequence 107 from Patent EP3020727.LQ789274 - Sequence 107 from Patent EP3339318.LV525519 - JP 2016537012-A/81: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289234 - KR 1020160068754-A/107: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633873 - Sequence 91 from Patent WO2015036599.LQ447256 - Sequence 91 from Patent EP3020727.LQ789258 - Sequence 91 from Patent EP3339318.LV525507 - JP 2016537012-A/69: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289222 - KR 1020160068754-A/91: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633833 - Sequence 51 from Patent WO2015036599.LQ447216 - Sequence 51 from Patent EP3020727.LQ789218 - Sequence 51 from Patent EP3339318.LV525477 - JP 2016537012-A/39: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289192 - KR 1020160068754-A/51: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633837 - Sequence 55 from Patent WO2015036599.LQ447220 - Sequence 55 from Patent EP3020727.LQ789222 - Sequence 55 from Patent EP3339318.LV525480 - JP 2016537012-A/42: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289195 - KR 1020160068754-A/55: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633801 - Sequence 19 from Patent WO2015036599.LP633841 - Sequence 59 from Patent WO2015036599.LP633845 - Sequence 63 from Patent WO2015036599.LQ447184 - Sequence 19 from Patent EP3020727.LQ447224 - Sequence 59 from Patent EP3020727.LQ447228 - Sequence 63 from Patent EP3020727.LQ789186 - Sequence 19 from Patent EP3339318.LQ789226 - Sequence 59 from Patent EP3339318.LQ789230 - Sequence 63 from Patent EP3339318.LV525453 - JP 2016537012-A/15: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525483 - JP 2016537012-A/45: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525486 - JP 2016537012-A/48: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289168 - KR 1020160068754-A/19: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289198 - KR 1020160068754-A/59: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289201 - KR 1020160068754-A/63: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633861 - Sequence 79 from Patent WO2015036599.LQ447244 - Sequence 79 from Patent EP3020727.LQ789246 - Sequence 79 from Patent EP3339318.LV525498 - JP 2016537012-A/60: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289213 - KR 1020160068754-A/79: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633849 - Sequence 67 from Patent WO2015036599.LQ447232 - Sequence 67 from Patent EP3020727.LQ789234 - Sequence 67 from Patent EP3339318.LV525489 - JP 2016537012-A/51: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289204 - KR 1020160068754-A/67: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633817 - Sequence 35 from Patent WO2015036599.LP633853 - Sequence 71 from Patent WO2015036599.LP633877 - Sequence 95 from Patent WO2015036599.LQ447200 - Sequence 35 from Patent EP3020727.LQ447236 - Sequence 71 from Patent EP3020727.LQ447260 - Sequence 95 from Patent EP3020727.LQ789202 - Sequence 35 from Patent EP3339318.LQ789238 - Sequence 71 from Patent EP3339318.LQ789262 - Sequence 95 from Patent EP3339318.LV525465 - JP 2016537012-A/27: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525492 - JP 2016537012-A/54: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525510 - JP 2016537012-A/72: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289180 - KR 1020160068754-A/35: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289207 - KR 1020160068754-A/71: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289225 - KR 1020160068754-A/95: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633809 - Sequence 27 from Patent WO2015036599.LQ447192 - Sequence 27 from Patent EP3020727.LQ789194 - Sequence 27 from Patent EP3339318.LV525459 - JP 2016537012-A/21: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289174 - KR 1020160068754-A/27: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633829 - Sequence 47 from Patent WO2015036599.LQ447212 - Sequence 47 from Patent EP3020727.LQ789214 - Sequence 47 from Patent EP3339318.LV525474 - JP 2016537012-A/36: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289189 - KR 1020160068754-A/47: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633821 - Sequence 39 from Patent WO2015036599.LP633857 - Sequence 75 from Patent WO2015036599.LP633881 - Sequence 99 from Patent WO2015036599.LQ447204 - Sequence 39 from Patent EP3020727.LQ447240 - Sequence 75 from Patent EP3020727.LQ447264 - Sequence 99 from Patent EP3020727.LQ789206 - Sequence 39 from Patent EP3339318.LQ789242 - Sequence 75 from Patent EP3339318.LQ789266 - Sequence 99 from Patent EP3339318.LV525468 - JP 2016537012-A/30: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525495 - JP 2016537012-A/57: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525513 - JP 2016537012-A/75: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289183 - KR 1020160068754-A/39: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289210 - KR 1020160068754-A/75: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289228 - KR 1020160068754-A/99: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633805 - Sequence 23 from Patent WO2015036599.LQ447188 - Sequence 23 from Patent EP3020727.LQ789190 - Sequence 23 from Patent EP3339318.LV525456 - JP 2016537012-A/18: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289171 - KR 1020160068754-A/23: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633797 - Sequence 15 from Patent WO2015036599.LQ447180 - Sequence 15 from Patent EP3020727.LQ789182 - Sequence 15 from Patent EP3339318.LV525450 - JP 2016537012-A/12: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289165 - KR 1020160068754-A/15: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633865 - Sequence 83 from Patent WO2015036599.LQ447248 - Sequence 83 from Patent EP3020727.LQ789250 - Sequence 83 from Patent EP3339318.LV525501 - JP 2016537012-A/63: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289216 - KR 1020160068754-A/83: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633789 - Sequence 7 from Patent WO2015036599.LQ447172 - Sequence 7 from Patent EP3020727.LQ789174 - Sequence 7 from Patent EP3339318.LV525444 - JP 2016537012-A/6: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289159 - KR 1020160068754-A/7: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633897 - Sequence 115 from Patent WO2015036599.LQ447280 - Sequence 115 from Patent EP3020727.LQ789282 - Sequence 115 from Patent EP3339318.LV525525 - JP 2016537012-A/87: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289240 - KR 1020160068754-A/115: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633813 - Sequence 31 from Patent WO2015036599.LP633893 - Sequence 111 from Patent WO2015036599.LQ447196 - Sequence 31 from Patent EP3020727.LQ447276 - Sequence 111 from Patent EP3020727.LQ789198 - Sequence 31 from Patent EP3339318.LQ789278 - Sequence 111 from Patent EP3339318.LV525462 - JP 2016537012-A/24: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525522 - JP 2016537012-A/84: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289177 - KR 1020160068754-A/31: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289237 - KR 1020160068754-A/111: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633793 - Sequence 11 from Patent WO2015036599.LP633825 - Sequence 43 from Patent WO2015036599.LP633901 - Sequence 119 from Patent WO2015036599.LP633905 - Sequence 123 from Patent WO2015036599.LP633909 - Sequence 127 from Patent WO2015036599.LP633913 - Sequence 131 from Patent WO2015036599.LP633917 - Sequence 135 from Patent WO2015036599.LP633921 - Sequence 139 from Patent WO2015036599.LP633925 - Sequence 143 from Patent WO2015036599.LQ447176 - Sequence 11 from Patent EP3020727.LQ447208 - Sequence 43 from Patent EP3020727.LQ447284 - Sequence 119 from Patent EP3020727.LQ447288 - Sequence 123 from Patent EP3020727.LQ447292 - Sequence 127 from Patent EP3020727.LQ447296 - Sequence 131 from Patent EP3020727.LQ447300 - Sequence 135 from Patent EP3020727.LQ447304 - Sequence 139 from Patent EP3020727.LQ447308 - Sequence 143 from Patent EP3020727.LQ789178 - Sequence 11 from Patent EP3339318.LQ789210 - Sequence 43 from Patent EP3339318.LQ789286 - Sequence 119 from Patent EP3339318.LQ789290 - Sequence 123 from Patent EP3339318.LQ789294 - Sequence 127 from Patent EP3339318.LQ789298 - Sequence 131 from Patent EP3339318.LQ789302 - Sequence 135 from Patent EP3339318.LQ789306 - Sequence 139 from Patent EP3339318.LQ789310 - Sequence 143 from Patent EP3339318.LV525447 - JP 2016537012-A/9: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525471 - JP 2016537012-A/33: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525528 - JP 2016537012-A/90: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525531 - JP 2016537012-A/93: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525534 - JP 2016537012-A/96: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525537 - JP 2016537012-A/99: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525540 - JP 2016537012-A/102: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525543 - JP 2016537012-A/105: Mutant calreticulin for the diagnosis of myeloid malignancies.LV525546 - JP 2016537012-A/108: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289162 - KR 1020160068754-A/11: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289186 - KR 1020160068754-A/43: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289243 - KR 1020160068754-A/119: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289246 - KR 1020160068754-A/123: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289249 - KR 1020160068754-A/127: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289252 - KR 1020160068754-A/131: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289255 - KR 1020160068754-A/135: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289258 - KR 1020160068754-A/139: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289261 - KR 1020160068754-A/143: Mutant calreticulin for the diagnosis of myeloid malignancies.LP633785 - Sequence 3 from Patent WO2015036599.LQ447168 - Sequence 3 from Patent EP3020727.LQ789170 - Sequence 3 from Patent EP3339318.LV525441 - JP 2016537012-A/3: Mutant calreticulin for the diagnosis of myeloid malignancies.LY289156 - KR 1020160068754-A/3: Mutant calreticulin for the diagnosis of myeloid malignancies.LP886335 - Sequence 227 from Patent WO2017201352.LP978092 - Sequence 227 from Patent WO2017120612.LF373320 - JP 2014500723-A/180823: Polycomb-Associated Non-Coding RNAs.JD188581 - Sequence 169605 from Patent EP1572962.JD301211 - Sequence 282235 from Patent EP1572962.JD253562 - Sequence 234586 from Patent EP1572962.LF373319 - JP 2014500723-A/180822: Polycomb-Associated Non-Coding RNAs.JD500697 - Sequence 481721 from Patent EP1572962.LF373318 - JP 2014500723-A/180821: Polycomb-Associated Non-Coding RNAs.JD282117 - Sequence 263141 from Patent EP1572962.JD093780 - Sequence 74804 from Patent EP1572962.JD555838 - Sequence 536862 from Patent EP1572962.JD205734 - Sequence 186758 from Patent EP1572962.JD307552 - Sequence 288576 from Patent EP1572962.JD390596 - Sequence 371620 from Patent EP1572962.LF373317 - JP 2014500723-A/180820: Polycomb-Associated Non-Coding RNAs.JD316211 - Sequence 297235 from Patent EP1572962.LQ980367 - Sequence 13 from Patent WO2013050532.MA608909 - JP 2018138019-A/180835: Polycomb-Associated Non-Coding RNAs.MA608908 - JP 2018138019-A/180834: Polycomb-Associated Non-Coding RNAs.MA608906 - JP 2018138019-A/180832: Polycomb-Associated Non-Coding RNAs.MA608905 - JP 2018138019-A/180831: Polycomb-Associated Non-Coding RNAs.MA608904 - JP 2018138019-A/180830: Polycomb-Associated Non-Coding RNAs.MA608903 - JP 2018138019-A/180829: Polycomb-Associated Non-Coding RNAs.MA608902 - JP 2018138019-A/180828: Polycomb-Associated Non-Coding RNAs.MA608901 - JP 2018138019-A/180827: Polycomb-Associated Non-Coding RNAs.MA608900 - JP 2018138019-A/180826: Polycomb-Associated Non-Coding RNAs.MA608899 - JP 2018138019-A/180825: Polycomb-Associated Non-Coding RNAs.MA608898 - JP 2018138019-A/180824: Polycomb-Associated Non-Coding RNAs.MA608897 - JP 2018138019-A/180823: Polycomb-Associated Non-Coding RNAs.MA608896 - JP 2018138019-A/180822: Polycomb-Associated Non-Coding RNAs.MA608895 - JP 2018138019-A/180821: Polycomb-Associated Non-Coding RNAs.MA608894 - JP 2018138019-A/180820: Polycomb-Associated Non-Coding RNAs.MA443761 - JP 2018138019-A/15687: Polycomb-Associated Non-Coding RNAs.MP273754 - Sequence 267 from Patent EP3494985.MP273758 - Sequence 271 from Patent EP3494985.MP273762 - Sequence 275 from Patent EP3494985.MP273766 - Sequence 279 from Patent EP3494985.MP273770 - Sequence 283 from Patent EP3494985.MP273774 - Sequence 287 from Patent EP3494985.MP273780 - Sequence 293 from Patent EP3494985.MP273784 - Sequence 297 from Patent EP3494985.MP273788 - Sequence 301 from Patent EP3494985.MP273792 - Sequence 305 from Patent EP3494985.MP273796 - Sequence 309 from Patent EP3494985.MP273800 - Sequence 313 from Patent EP3494985.MP273804 - Sequence 317 from Patent EP3494985.MP273808 - Sequence 321 from Patent EP3494985.MP273812 - Sequence 325 from Patent EP3494985.MP273816 - Sequence 329 from Patent EP3494985.MP273820 - Sequence 333 from Patent EP3494985.MP273824 - Sequence 337 from Patent EP3494985.MP273828 - Sequence 341 from Patent EP3494985.MP273832 - Sequence 345 from Patent EP3494985.MP273836 - Sequence 349 from Patent EP3494985.MP273840 - Sequence 353 from Patent EP3494985.MP273844 - Sequence 357 from Patent EP3494985.MP273848 - Sequence 361 from Patent EP3494985.MP273852 - Sequence 365 from Patent EP3494985.MP273856 - Sequence 369 from Patent EP3494985.MP273860 - Sequence 373 from Patent EP3494985.MP273864 - Sequence 377 from Patent EP3494985.MP273868 - Sequence 381 from Patent EP3494985.MP273872 - Sequence 385 from Patent EP3494985.MP273876 - Sequence 389 from Patent EP3494985.MP273880 - Sequence 393 from Patent EP3494985.MP273884 - Sequence 397 from Patent EP3494985.MP273888 - Sequence 401 from Patent EP3494985.MP273892 - Sequence 405 from Patent EP3494985.MP273896 - Sequence 409 from Patent EP3494985.MP273900 - Sequence 413 from Patent EP3494985.MP273904 - Sequence 417 from Patent EP3494985.MP273908 - Sequence 421 from Patent EP3494985.MP273912 - Sequence 425 from Patent EP3494985.MP273916 - Sequence 429 from Patent EP3494985.MP273920 - Sequence 433 from Patent EP3494985.MP273634 - Sequence 147 from Patent EP3494985.MP273638 - Sequence 151 from Patent EP3494985.MP273642 - Sequence 155 from Patent EP3494985.MP273646 - Sequence 159 from Patent EP3494985.MP273650 - Sequence 163 from Patent EP3494985.MP273654 - Sequence 167 from Patent EP3494985.MP273658 - Sequence 171 from Patent EP3494985.MP273662 - Sequence 175 from Patent EP3494985.MP273666 - Sequence 179 from Patent EP3494985.MP273670 - Sequence 183 from Patent EP3494985.MP273674 - Sequence 187 from Patent EP3494985.MP273678 - Sequence 191 from Patent EP3494985.MP273682 - Sequence 195 from Patent EP3494985.MP273686 - Sequence 199 from Patent EP3494985.MP273690 - Sequence 203 from Patent EP3494985.MP273694 - Sequence 207 from Patent EP3494985.MP273698 - Sequence 211 from Patent EP3494985.MP273702 - Sequence 215 from Patent EP3494985.MP273706 - Sequence 219 from Patent EP3494985.MP273710 - Sequence 223 from Patent EP3494985.MP273714 - Sequence 227 from Patent EP3494985.MP273718 - Sequence 231 from Patent EP3494985.MP273722 - Sequence 235 from Patent EP3494985.MP273726 - Sequence 239 from Patent EP3494985.MP273730 - Sequence 243 from Patent EP3494985.MP273734 - Sequence 247 from Patent EP3494985.MP273738 - Sequence 251 from Patent EP3494985.MP273742 - Sequence 255 from Patent EP3494985.MP273746 - Sequence 259 from Patent EP3494985.MP273750 - Sequence 263 from Patent EP3494985.MP273574 - Sequence 87 from Patent EP3494985.MP273590 - Sequence 103 from Patent EP3494985.MP273594 - Sequence 107 from Patent EP3494985.MP273578 - Sequence 91 from Patent EP3494985.MP273538 - Sequence 51 from Patent EP3494985.MP273542 - Sequence 55 from Patent EP3494985.MP273506 - Sequence 19 from Patent EP3494985.MP273546 - Sequence 59 from Patent EP3494985.MP273550 - Sequence 63 from Patent EP3494985.MP273566 - Sequence 79 from Patent EP3494985.MP273554 - Sequence 67 from Patent EP3494985.MP273522 - Sequence 35 from Patent EP3494985.MP273558 - Sequence 71 from Patent EP3494985.MP273582 - Sequence 95 from Patent EP3494985.MP273514 - Sequence 27 from Patent EP3494985.MP273534 - Sequence 47 from Patent EP3494985.MP273526 - Sequence 39 from Patent EP3494985.MP273562 - Sequence 75 from Patent EP3494985.MP273586 - Sequence 99 from Patent EP3494985.MP273510 - Sequence 23 from Patent EP3494985.MP273502 - Sequence 15 from Patent EP3494985.MP273570 - Sequence 83 from Patent EP3494985.MP273494 - Sequence 7 from Patent EP3494985.MP273602 - Sequence 115 from Patent EP3494985.MP273518 - Sequence 31 from Patent EP3494985.MP273598 - Sequence 111 from Patent EP3494985.MP273498 - Sequence 11 from Patent EP3494985.MP273530 - Sequence 43 from Patent EP3494985.MP273606 - Sequence 119 from Patent EP3494985.MP273610 - Sequence 123 from Patent EP3494985.MP273614 - Sequence 127 from Patent EP3494985.MP273618 - Sequence 131 from Patent EP3494985.MP273622 - Sequence 135 from Patent EP3494985.MP273626 - Sequence 139 from Patent EP3494985.MP273630 - Sequence 143 from Patent EP3494985.MP273490 - Sequence 3 from Patent EP3494985.MB419114 - JP 2019519516-A/76: MRNA COMBINATION THERAPIES FOR THE TREATMENT OF CANCER.MB419979 - JP 2019519516-A/941: MRNA COMBINATION THERAPIES FOR THE TREATMENT OF CANCER.
Biochemical and Signaling Pathways
BioCarta from NCI Cancer Genome Anatomy Project h_nfatPathway - NFAT and Hypertrophy of the heart (Transcription in the broken heart)
Other Names for This Gene
Alternate Gene Symbols: ENST00000316448.1, ENST00000316448.2, ENST00000316448.3, ENST00000316448.4, ENST00000316448.5, ENST00000316448.6, ENST00000316448.7, ENST00000316448.8, ENST00000316448.9, HEL-S-99n , NM_004343, uc317qai.1, uc317qai.2, V9HW88, V9HW88_HUMANUCSC ID: ENST00000316448.10_6RefSeq Accession: NM_004343.4
Gene Model Information
Click here
for a detailed description of the fields of the table above.
Methods, Credits, and Use Restrictions
Click here
for details on how this gene model was made and data restrictions if any.
US Server
Sequence and Links to Tools and Databases 
Common Gene Haplotype Alleles 